Loading...
BioRem Inc.
BIRMF•PNK
Industrials
Industrial - Pollution & Treatment Controls
$1.52
$-0.04(-2.56%)
BioRem Inc. (BIRMF) Financial Performance & Income Statement Overview
Review BioRem Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
48.69%
↑ 48.69%
Operating Income Growth
41.84%
↑ 41.84%
Net Income Growth
39.66%
↑ 39.66%
Operating Cash Flow Growth
652.010%
↑ 652.010%
Operating Margin
10.83%
↑ 10.83%
Gross Margin
25.91%
↑ 25.91%
Net Profit Margin
7.56%
↑ 7.56%
ROE
27.98%
↑ 27.98%
ROIC
29.30%
↑ 29.30%
BioRem Inc. (BIRMF) Income Statement & Financial Overview
Review BioRem Inc.'s (BIRMF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $9.32M | $14.89M | $7.30M | $5.92M |
| Cost of Revenue | $7.72M | $9.86M | $5.64M | $4.14M |
| Gross Profit | $1.60M | $5.02M | $1.66M | $1.78M |
| Gross Profit Ratio | $0.17 | $0.34 | $0.23 | $0.30 |
| R&D Expenses | $7138.00 | $7944.00 | $13512.00 | $15265.00 |
| SG&A Expenses | $1.30M | $1.99M | $1.13M | $1.20M |
| Operating Expenses | $1.31M | $1.99M | $1.14M | $1.22M |
| Total Costs & Expenses | $9.03M | $11.86M | $6.79M | $5.36M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $46930.00 | $47429.00 | $50117.00 | $50949.00 |
| Depreciation & Amortization | $139966.00 | $184657.00 | $74829.00 | $73674.00 |
| EBITDA | $426542.00 | $3.21M | $587291.00 | $634550.00 |
| EBITDA Ratio | $0.05 | $0.22 | $0.08 | $0.11 |
| Operating Income | $286576.00 | $3.03M | $513070.00 | $560880.00 |
| Operating Income Ratio | $0.03 | $0.20 | $0.07 | $0.09 |
| Other Income/Expenses (Net) | -$46930.00 | -$47429.00 | -$50117.00 | -$95881.00 |
| Income Before Tax | $239646.00 | $2.98M | $462345.00 | $465000.00 |
| Income Before Tax Ratio | $0.03 | $0.20 | $0.06 | $0.08 |
| Income Tax Expense | $68910.00 | $790342.00 | $122521.00 | $120900.00 |
| Net Income | $170736.00 | $2.19M | $339824.00 | $344099.00 |
| Net Income Ratio | $0.02 | $0.15 | $0.05 | $0.06 |
| EPS | $0.01 | $0.14 | $0.02 | $0.02 |
| Diluted EPS | $0.00 | $0.12 | $0.02 | $0.02 |
| Weighted Avg Shares Outstanding | $16.14M | $15.80M | $15.70M | $15.70M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $18.58M | $18.52M | $15.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan